Comment
doi: 10.1136/eb-2014-101757.
Epub 2014 May 1.
The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time
Affiliations
- PMID: 24785468
- DOI: 10.1136/eb-2014-101757
Item in Clipboard
Comment
The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time
Evid Based Med.
2014 Oct.
No abstract available
Comment on
-
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.BMJ. 2014 Jan 16;348:g130. doi: 10.1136/bmj.g130. BMJ. 2014. PMID: 24435414 Free PMC article. Clinical Trial.
Similar articles
-
More education is needed before we burden women with their HPV status.BMJ. 2014 Feb 12;348:g1443. doi: 10.1136/bmj.g1443. BMJ. 2014. PMID: 24523378 No abstract available.
-
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.BMJ. 2014 Jan 16;348:g130. doi: 10.1136/bmj.g130. BMJ. 2014. PMID: 24435414 Free PMC article. Clinical Trial.
-
[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 16635326 Chinese.
-
HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46. doi: 10.1016/S0020-7292(06)60039-8. Int J Gynaecol Obstet. 2006. PMID: 17161163 Review. No abstract available.
-
HPV testing in cervical screening.Pharmacoepidemiol Drug Saf. 2001 Jan-Feb;10(1):33-6. doi: 10.1002/pds.558. Pharmacoepidemiol Drug Saf. 2001. PMID: 11417064 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
